A Partner Newsletter: CDC FINDS NO LINK BETWEEN COVID-19 VACCINES AND CARDIAC DEATH IN YOUNG PEOPLE

CDC FINDS NO LINK BETWEEN COVID-19 VACCINES AND CARDIAC DEATH IN YOUNG PEOPLE

Last week the Centers for Disease Control and Prevention (CDC) published a study by Dr. Juventila Liko and Dr. Paul R. Cieslak which looks at the assessment of risk for sudden cardiac death among adolescents and young adults after receipt of the COVID-19 vaccine. Their abstract explains:

“COVID-19 vaccination has been associated with myocarditis in adolescents and young adults, and concerns have been raised about possible vaccine-related cardiac fatalities in this age group. In April 2021, cases of myocarditis after COVID-19 vaccination, particularly among young male vaccine recipients, were reported to the Vaccine Adverse Event Reporting System. To assess this possibility, investigators searched death certificates for Oregon residents aged 16–30 years who died during June 2021–December 2022 for cardiac or undetermined causes of death.

For identified decedents, records in Oregon’s immunization information system were reviewed for documentation of mRNA COVID-19 vaccination received ≤100 days before death. Among 1,292 identified deaths, COVID-19 was cited as the cause for 30. For 101 others, a cardiac cause of death could not be excluded; among these decedents, immunization information system records were available for 88, three of
whom had received an mRNA COVID-19 vaccination within 100 days of death. Of 40 deaths that occurred among persons who had received an mRNA COVID-19 vaccine dose, three occurred ≤100 days after vaccination. Two of these deaths were attributed to chronic underlying conditions; the cause was undetermined for one. No death certificate attributed death to vaccination.

These data do not support an association between receipt of mRNA COVID-19 vaccine and sudden cardiac death among previously healthy young persons. COVID-19 vaccination is recommended for all persons aged ≥6 months to prevent COVID-19 and complications, including death.”

Recent findings also support existing recommendations that children and adolescents aged 5–18 years remain up to date with COVID-19 vaccination given low vaccination coverage and waning effectiveness over time against COVID–19–related hospitalizations.

View the full report here.

View the myocarditis fact sheet from DOH here.

Translate »